drugset
drugset / Trial / NCT04490434

Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs

NCT04490434 ↗

Phase 1 Unknown 110 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverDouble-blindBasic science

Summary

drug-drug interaction between DWP14012 and three different kinds of NSAIDs

Timeline

Start
2020-06-19
Primary completion
2020-08-31
Completion
2020-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject ABEPRAZAN Small molecule 40 mg —
Subject Celecoxib Other / unclassified 200 mg —
Subject Meloxicam Small molecule 15 mg —
Subject Naproxen Small molecule 500 mg —

Indications

No indication recorded.